2003
DOI: 10.1016/s0304-3835(02)00675-4
|View full text |Cite
|
Sign up to set email alerts
|

Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
35
3
4

Year Published

2003
2003
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 51 publications
(43 citation statements)
references
References 17 publications
1
35
3
4
Order By: Relevance
“…Moreover, 1 study (8) was replaced with its updated version since the subjects in these 2 studies were from the same population. The final pool of eligible studies consisted of 13 studies with 1,936 cases and 2,858 controls (3,6,12,13,15,17,(21)(22)(23)(24)(25)(26)(27) for MTHFR C677T polymorphism (Table I), 5 studies with 585 cases and 1,000 controls for MTHFR A1298C polymorphism (Table I), and 3 studies with 389 cases and 440 controls for MS A2756G polymorphism (Table I). The genotype distribution in the controls of all these studies was consistent with HWE.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Moreover, 1 study (8) was replaced with its updated version since the subjects in these 2 studies were from the same population. The final pool of eligible studies consisted of 13 studies with 1,936 cases and 2,858 controls (3,6,12,13,15,17,(21)(22)(23)(24)(25)(26)(27) for MTHFR C677T polymorphism (Table I), 5 studies with 585 cases and 1,000 controls for MTHFR A1298C polymorphism (Table I), and 3 studies with 389 cases and 440 controls for MS A2756G polymorphism (Table I). The genotype distribution in the controls of all these studies was consistent with HWE.…”
Section: Resultsmentioning
confidence: 99%
“…One study (8) was replaced with its updated version due to overlapping inclusion of study subjects in the most recent study. The eligible studies comprised 7 studies (3,6,17,21,24,26,27) with 1,936 cases and 2,858 controls for MTHFR C677T polymorphism (Table I) and the genotype distribution in the controls of all these studies was consistent with HWE. There were not enough studies available for the meta-analysis of the contribution of MTHFR A1298C or MS A2756G polymorphisms to susceptibility to CIN II/III.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…After discarding those which clearly did not meet the criteria, 19 studies were further assessed for eligibility (Piyathilake et al, 2000;Goodman et al, 2001;Gerhard et al, 2003;Lambropoulos et al, 2003;Sull et al, 2004;Kang et al, 2005;Zoodsma et al, 2005;Delgado-Enciso et al, 2006;Rao et al, 2006;Piyathilake et al, 2007;Nandan et al, 2008;Shekari et al, 2008;Agodi et al, 2010;Kohaar et al, 2010;Tong et al, 2010;Mostowska et al, 2011;Prasad and Wilkhoo, 2011;Tong et al, 2011;von Keyserling et al, 2011). After reviewing each original paper and extracting data, nine studies were excluded including five studies focusing on cervical intraepithelial neoplasia (Piyathilake et al, 2000;Goodman et al, 2001;Lambropoulos et al, 2003;Piyathilake et al, 2007;Agodi et al, 2010), three studies for not specifying genotypic frequencies of CC, CT, and TT (Gerhard et al, 2003;Nandan et al, 2008;Rao et al, 2006) and one study for overlapping data (Tong et al, 2010). Finally, 10 casecontrol studies with a total of 2113 cervical cancer cases and 2804 controls were included into this meta-analysis (Sull et al, 2004;Kang et al, 2005;Zoodsma et al, 2005;Delgado-Enciso et al, 2006;Shekari et al, 2008;Kohaar et al, 2010;Mostowska et al, 2011;...…”
Section: Characteristics Of Includes Studiesmentioning
confidence: 99%